V

Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX)

13 employees

Virpax is developing differentiated treatment options that address unmet needs in three multi-billion-dollar markets

Basic info

pharmaceutical manufacturing

Chronic Pain Mainagement

Pharmaceutical

psychological

Life Science

Osteoarthritis pain

Acute Pain

Neuroscience

Arthroplasty

Product Research

Nanotechnology

Neurological

Post Operative Pain Management

antivirals

PTSD

Biopharma

CNS Disorders

Health Care

Market Research

Respiratory Infection

Pain Management

Marketing

Cancer Pain

Non-addictive

Surgical Pain

Epilepsy

Psychology

2017